Atlas Trials

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study

Clinical trial NCT05131477 · COMPLETED

Trial details

NCT number
NCT05131477
Sponsor
Kymab Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
EczemaAtopic Dermatitis
Start date
2021-12-13
Primary completion
2023-04-26
Enrollment
390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.